Quantifying Changes in the Thoracic Wall After Nuss Bar Removal in Pectus Excavatum Patients Using 3D Imaging (CHEST)

March 23, 2026 updated by: Erik de Loos

Quantification of Thoracic Wall Changes Using Three-dimensional Optical Imaging After Nuss Bar Removal

Pectus excavatum (funnel chest) is the most common congenital anterior thoracic wall deformity. It can be associated not only with cosmetic concerns but also with psychosocial and limiting somatic complaints. Patients with this condition are often treated surgically using the Nuss bar procedure, in which a metal bar is placed behind the sternum to effectively "pop out" the funnel chest. This bar typically remains in place for 2-3 years.

To analyze how the thoracic wall changes after removal of the Nuss bar, we aim to capture three-dimensional (3D) images at four different time points: just before removal, immediately after, and at 6 and 12 months post-removal. When significant changes over time are detected, we aim to identify factors that may predict retraction or recurrence. Based on these predictive factors, individualized decision-making regarding the timing of Nuss bar removal can be optimized to minimize the risk of retraction or recurrence.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

69

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Heerlen, Netherlands
        • Zuyderland Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients with pectus excavatum who are visit our outpatient clinic and are scheduled for the removal of their Nuss bar.

Description

Inclusion Criteria:

  • Patients of all ages and genders with a Nuss bar eligible for removal.

Exclusion Criteria:

  • Patients in whom the bar or stabilizing components were dislocated
  • Patients who underwent a second surgery for their pectus excavatum following the initial placement of the Nuss bar
  • Patients in whom retrosternal metal bars have been placed for any indication other than the treatment of pectus excavatum
  • Patients with connective tissue disorders such as Marfan syndrome
  • Patients diagnosed with epilepsy
  • Patients who are unable to maintain a stationary standing position for approximately 60 seconds

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Postoperative 3D scans

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
External Haller index
Time Frame: just before removal, immediately after, and at 6 and 12 months post-removal.
just before removal, immediately after, and at 6 and 12 months post-removal.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2020

Primary Completion (Actual)

January 6, 2025

Study Completion (Actual)

January 6, 2025

Study Registration Dates

First Submitted

March 23, 2026

First Submitted That Met QC Criteria

March 23, 2026

First Posted (Actual)

March 27, 2026

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 23, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pectus Excavatum

Subscribe